Real-World Evidence (RWE)

Is Your RWE Study In the Weeds? Meet Some Experts Who Can Help.

Faster to Market: Transforming HEOR & RWE Using Virtual Sourcing

Closing Gaps in Care: Health Equity and the Inflation Reduction Act - A Cutting Edge Conversation

RWE reality check: Routine patient health records and regulatory requirements

"S" Stands for Systematic: Demystifying the Systematic Literature Review

The Scientific and Operational Elegance of Study Replication with Real-World EHR Data: A Vitiligo and Alopecia Example

Practical AI: Adding Insight to the Patient Journey with Digital Phenotyping

Insights from the 2024 Salary Survey Report by HealthEconomics.com

Beyond Accelerated Approvals: External Control Arms

Delphi Panels: What Are They Good For?

Patient Voices Matter: Transforming Industry-Sponsored Real-World Evidence with Patient-Centric Approaches

Integrated Evidence Generation Planning: Driving Successful Reimbursement and Life Cycle Management

Bridging the Gap: Strategies for Patient-Centered Real-World Evidence in Rare Diseases

The role of patient-centric technologies & tokenization in RWE studies

Partnering with Disease Registries: The Value and Impact for Real-World Evidence Generation

Synthesise RWE and AI. Transform patient-driven healthcare

Transforming clinical research: Scaling real-world data across diseases with expert-led AI

Improving Patient Outcomes: AI-Based Phenotyping for Diagnosis, Treatment, and Clinical Trials

How to assess the quality of AI output when structuring unstructured medical data

What Every Researcher Needs to Know About Using Medicare Data for Real World Evidence

Economic Impact of Representativeness in Clinical Trials: How Real-World Data Can Help

How to Supercharge Real World Evidence Generation in Phase IV Trials

Keeping pace with the evolving global landscape in vaccine development

Improving Treatment Access & Outcomes by Integrating Social Determinants of Health Data with Real-World Evidence

Designing Causal Inference Studies Using Real-World Data

Social Media Data: Opportunities and Insights for Clinical Research

The Future of Real-World Evidence: Pharma's Next Moves, Upcoming Webinar Hosted by Xtalks

Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access

An Introduction to Infectious Disease Modeling

Syapse Real-World Dialogue: Advancing Patient Care through Real-World Data, Machine Learning, and Systems Biology

Evidence Synthesis for Sparse Evidence Base, Heterogeneous Studies, and Disconnected Networks

Optimize Your Value Story Through Integrated Evidence Generation - From Bench to Patient

Using Real-World Data to Explore and Demonstrate Comparative Effectiveness

Informing Market Access Earlier in Clinical Development: Prospective RWE Research to Characterize Real World Patient Populations

FDA Guidance Documents: Shaping the Future of RWD Curation and RWE Innovation

How Cerner Enviza Uses Clinical Data to Drive RWE Decisions

Cracking the Code: When and How to Validate ICD Algorithms for RWE

Optimizing Real-World Evidence for Maternal and Neonatal Outcomes

How Literature Review Automation and Efficient Processes Streamline RWE HEOR Studies

Cutting Edge Conversations: Addressing Orphan and Rare Diseases

Marketplaces Drive Faster Science: HEOR, RWE & Market Access Sourcing

Marketplaces Drive Faster Science: HEOR, RWE & Market Access Sourcing

Patient-Centric RWE Research & Remote Monitored Care: Learnings from a support program leveraging telehealth & connected devices

Value-Based Agreements - Are We Going to See More or Less of Them?

Can Literature Review Automation Improve Healthcare Cost-Effectiveness Analysis and Budget Impact Modeling Outcomes?

Using External Control Arm Studies in HTA Submissions: An Alternative, When RCTs are not Feasible

Overcoming Clinical Research Challenges: Analyzing EHR Data to Replicate Clinical Trials and Construct External Control Arms

The Value of a Multi-Source Real-World Data Strategy: How to Overcome Gaps and Limitations

Real World Evidence for COVID-19: Making an impact now and into the future

INsights & OUTcomes with Mark Larkin

INsights & OUTcomes with Radek Wasiak

Weekly News Roundup - CAR-T Safety Alerts, Policy Ripple Effects, and Notable Wearables

Weekly News Roundup - Immunology, Innovation, and Impact

Weekly News Roundup - Medicaid Deals, Oncology Innovation, and Market Tensions Abroad

Weekly News Roundup - Vaccine Policy Shifts, AI-Powered R&D, and Billion-Dollar Investments

Weekly News Roundup - Pharma Acquisitions, Trial Triumphs, and Coding Controversies

Weekly News Roundup - Obesity Drug Rivalry, Rare Disease Pathways, Vaccine Mandate Battles, and ACA Shake-Ups

Weekly News Roundup - Ransomware Shocks, Vaccine Policy Shifts, and Billion-Dollar Pharma Investments

Weekly News Roundup - Alzheimer's Breakthroughs, Cancer Trial Advances, and High-Stakes Policy Battles

Weekly News Roundup - Pharmacist Empowerment, Financial Shifts, and Innovative Health Solutions

Weekly News Roundup - Pharma Pilots, Legal Battles, and Precision Medicine Breakthroughs

Weekly News Roundup - Vaccine Triumphs, Revolutionary Trials, and Data-Driven Health Futures

Meeting the Resource Challenge - Why Biotechs Need a Different Kind of Partner

INsights & OUTcomes with Matt McLoughlin

Podcast Q&A: Patient-Centered Real-World Evidence in Rare Diseases

Podcast Q&A: Real-World Evidence Generation with Disease Registries

Podcast Q&A: Clinical Outcome Assessment (COA) Translations

The Future of Diversity in Clinical Trials: Real-World Evidence

Podcast Q&A: Improving the Representativeness of Research

Podcast Q&A: Literature Reviews and Global Value Dossiers

Podcast Q&A: Platforms and Models for Payer Insights and Evidence Generation

Podcast Q&A: Evidence Generation Planning

Algorithms for Real World Evidence

Podcast Q&A: Real-World Evidence and Neonatal Outcomes